21 March 2022
Featured post

Choose targets with low risk of side effects pinpointed by Ardigen's ARDitox platform

Read more

Blog

Choose targets with low risk of side effects pinpointed by Ardigen's ARDitox platform
21 March 2022
Choose targets with low risk of side effects pinpointed by Ardigen's ARDitox platform
Read more
Unconventional γδ T cells as allogeneic cellular products in immunotherapies for cancer.
7 February 2022
Unconventional γδ T cells as allogeneic cellular products in immunotherapies for cancer.
Read more
Gut microbiota’s road to clinical utilization. From bathroom to bedside.
07 October 2021
Gut microbiota’s road to clinical utilization. From bathroom to bedside.
Read more
Off-the-Shelf allogeneic cellular immunotherapies for cancer
15 September 2021
Off-the-Shelf allogeneic cellular immunotherapies for cancer
Read more
Current and future directions in CAR-T and TCR-T cell therapies against solid tumors
29 June 2021
Current and future directions in CAR-T and TCR-T cell therapies against solid tumors
Read more
Conformal Prediction in Classification
2 June 2021
Conformal Prediction in Classification
Read more
Go up